drugset / Trial / NCT02601898

Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment

NCT02601898

Phase 4 Completed 54 enrolled Azienda USL Ferrara
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study was to compare the therapeutic efficacy of lipoic acid versus progesterone by vaginal administration on subchorionic hematoma resorption in women at the first trimester of pregnancy with threatened miscarriage.

Timeline

Start
2015-01
Primary completion
2015-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Intravenous